International Survey of Clinical Practice Exploring Use of Platinum-Etoposide Chemotherapy for Extra-Pulmonary High Grade Neuroendocrine Carcinoma (EP-G3-NEC)

#2034

Introduction: Platinum-etoposide (PE) chemotherapy (CH) is a globally established combination for EP-G3-NEC; the optimal schedule has not been established.

Aim(s): The aim was to explore which PE CH schedules are in use across centres, to assess consistency in clinical practice.

Materials and methods: An international survey was designed, and completed by clinicians with an expertise in the field.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Lamarca A

Authors: Lamarca A, Frizziero M, Barriuso J, McNamara M, Hubner R,

Keywords: high grade, neuroendocrine, survey, chemotherapy, platinum, etoposide,